Insomnia

What insomnia is

Clinically, insomnia is defined as difficulty falling asleep, difficulty staying asleep, or waking earlier than desired — combined with measurable impact on daytime function. The daytime component matters: poor sleep without daytime consequence is not technically insomnia, even when it's frustrating.

Insomnia is categorized by duration:

• Acute insomnia — under three months, typically tied to a specific stressor (illness, bereavement, work crisis, jet lag). Often resolves when the stressor resolves.
• Chronic insomnia — sleep difficulty at least three nights per week for at least three months, with daytime impact. This is the form that benefits from formal treatment.

For decades, insomnia was sub-classified as "primary" (a standalone condition) or "secondary" (caused by another condition). Modern sleep medicine has largely abandoned that distinction. Most chronic insomnia today is understood as comorbid — coexisting with depression, anxiety, chronic pain, or another sleep disorder — and warranting direct treatment of the insomnia itself even when the comorbid condition is also treated.

The three patterns

Chronic insomnia presents in three primary patterns, distinguished by when in the night the disruption happens:

• Sleep-onset insomnia — difficulty falling asleep at the start of the night, typically taking more than 30 minutes to drift off despite feeling tired. Most often associated with anxiety, racing thoughts, or circadian misalignment.
• Sleep-maintenance insomnia — falling asleep without difficulty but waking repeatedly through the night and struggling to return to sleep. Most often associated with comorbid medical conditions, alcohol use, untreated sleep apnea, or chronic pain.
• Early-morning awakening insomnia — waking earlier than intended (typically two or more hours before the desired time) and unable to return to sleep. Most strongly associated with depression and with circadian phase advance.

Many patients have a mixed pattern combining two or all three types. The pattern often points toward likely contributors — and sometimes toward specific treatment adjustments — but it is not itself a separate diagnosis.

Symptoms and daytime impact

Nighttime symptoms are usually obvious to the person experiencing them: difficulty falling asleep, frequent awakenings, early waking, light or non-restorative sleep, and frustration at lying awake. The daytime consequences are equally significant and often underappreciated:

• Persistent fatigue not fully relieved by sleep opportunity
• Difficulty concentrating, slowed thinking, and short-term memory problems
• Mood disturbance — irritability, low mood, anxiety
• Reduced motivation and decreased ability to enjoy daily activities
• Increased risk of motor vehicle accidents and workplace errors
• Elevated long-term risk of cardiovascular disease, type 2 diabetes, and depression

The structural difference between healthy and insomnia sleep is substantial: not just less total sleep, but qualitatively different sleep, with fragmented cycles and substantially reduced time in restorative deep sleep. This is why even a person with insomnia who spends nine hours in bed can wake feeling unrested — the time in bed isn't translating into the right kind of sleep.

What causes chronic insomnia

Modern sleep medicine uses a "3-P" framework to understand chronic insomnia:

• Predisposing factors — baseline traits that make someone vulnerable: high baseline arousal, family history of insomnia, perfectionism or worry-prone temperament, female sex, and older age.
• Precipitating factors — events that trigger an episode: job stress, illness, bereavement, relationship transitions, jet lag, hospitalization.
• Perpetuating factors — behaviors and beliefs that keep insomnia going after the original trigger has resolved: spending excess time in bed trying to "make up" sleep, daytime napping, anxiety about not sleeping, and conditioned associations between bed and wakefulness.

The third category is the one CBT-I targets most directly. Many chronic insomnia patients describe an arc: a stressful period years ago disrupted their sleep, the original stressor resolved, but the insomnia persisted because of behavioral and cognitive patterns that developed in response to it. The original cause is gone, but the perpetuating patterns remain.

Common comorbidities and contributors

• Mental health conditions — anxiety, depression, and PTSD are bidirectionally associated with insomnia; treating one usually requires attention to the other
• Other sleep disorders — particularly obstructive sleep apnea and restless legs syndrome, both of which can present primarily as insomnia symptoms
• Medical conditions — chronic pain, GERD, hyperthyroidism, nocturia from various causes, menopausal hot flashes
• Medications — certain antihypertensives, decongestants, corticosteroids, stimulants, and some antidepressants can disrupt sleep
• Substances — alcohol (which fragments sleep despite its sedating onset), caffeine consumed late in the day, nicotine
• Circadian misalignment — shift work, jet lag, irregular schedules

How insomnia is diagnosed

Insomnia is a clinical diagnosis. Unlike sleep apnea, it does not generally require an overnight sleep study. The diagnostic process centers on the clinical interview and a sleep diary.

Clinical interview

A sleep specialist or trained primary care physician will ask about sleep onset, awakenings, total sleep, daytime symptoms, duration of the problem, prior treatments, medication and substance use, and screening for comorbid mental health and medical conditions. The interview alone is often sufficient to establish the diagnosis.

Sleep diary

A one-to-two-week sleep diary — recording bedtime, sleep latency, awakenings, wake time, and quality — is the single most useful diagnostic and treatment-planning tool. It frequently reveals patterns the patient hasn't recognized, including the gap between time in bed and actual sleep time that perpetuates the cycle.

Validated questionnaires

The Insomnia Severity Index and Pittsburgh Sleep Quality Index are widely used to quantify severity and track response to treatment. These supplement the interview rather than replacing it.

When polysomnography is appropriate

An overnight sleep study is not routinely needed for insomnia. It is recommended when another sleep disorder is suspected — particularly when a bed partner reports loud snoring, witnessed breathing pauses, or restless leg movements — or when initial treatment has failed and a comorbid disorder is suspected.

Treatment: CBT-I as first-line

The treatment landscape for chronic insomnia has shifted significantly in the past decade. The American Academy of Sleep Medicine, American College of Physicians, and NIH all now recommend cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia in adults — including in patients with comorbid depression, anxiety, and chronic pain.

What CBT-I involves

CBT-I is typically delivered over four to eight sessions with a trained therapist. It combines several evidence-based components:

• Sleep restriction therapy — temporarily limiting time in bed to closely match actual sleep time, then gradually expanding the sleep window as efficiency improves. Counterintuitive but the most powerful single component.
• Stimulus control — using the bed only for sleep (not work, not screens, not lying awake worrying). If unable to sleep within roughly 20 minutes, leaving the bed and returning only when sleepy.
• Cognitive restructuring — identifying and addressing dysfunctional beliefs about sleep ("if I don't get eight hours, tomorrow is ruined"), which often perpetuate the cycle.
• Sleep hygiene education — basic environmental and behavioral practices that support consistent sleep.
• Relaxation training — progressive muscle relaxation, breathing techniques, or guided imagery to reduce pre-sleep arousal.

CBT-I is effective for approximately 70-80% of patients. Improvements are typically durable, often persisting years after the active treatment ends — a contrast with sleep medications, where benefits generally end when the medication is stopped.

Digital CBT-I

Several validated digital CBT-I programs (delivered via app or web) have shown comparable efficacy to in-person therapy in clinical trials. These are often a faster, lower-cost path to treatment, particularly in regions where in-person CBT-I providers are scarce.

Pharmacotherapy

Several classes of medication can be used as adjuncts to CBT-I or for short-term symptom relief. Long-term use of sleep medications has tradeoffs that are best discussed with a sleep specialist or knowledgeable primary care physician — there is no single "best" sleep medication, and the choice depends on the type of insomnia, comorbidities, and individual response. Pharmacotherapy is best understood as a complement to behavioral treatment rather than a substitute for it.

When to see a sleep specialist

A sleep evaluation is appropriate if any of the following apply:

• Sleep difficulty at least three nights per week, persisting for three months or longer
• Insomnia significantly affects daytime function, mood, or quality of life
• You've made reasonable adjustments to sleep hygiene without improvement
• You've been using prescription or over-the-counter sleep medications regularly without specialist guidance
• A bed partner reports loud snoring, witnessed breathing pauses, or restless leg movements (suggesting comorbid OSA or RLS)
• Insomnia coexists with significant depression, anxiety, or PTSD
• Insomnia emerged or worsened around perimenopause or menopause

Effective CBT-I providers can be located through the CBT-I provider directory maintained by the Society of Behavioral Sleep Medicine, or through a referral from a primary care physician or sleep specialist.